Thursday, October 29, 2020

Food and Beverage

Emerging Growth Food and Beverage Companies

Throw $5,000.00 into any of these Coronavirus Vaccine Stocks

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Cheap Stocks to own before the Election

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

The Stocks behind President Trump’s Recovery.

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Support for a new class of Diabetes Drugs

Numerous companies are hard at work developing diabetes treatments and tools that relieve the pain of this deadly disease. DexCom (NASDAQ: DXCM), Livongo Health (NASDAQ: LVGO), and Tandem Diabetes Care (NASDAQ: TNDM) are three companies involved in diabetes care that you should keep an eye on as we transition to the second half of 2020.

The Best Blockchain Stocks to Own

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 revenues which increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

M&A in Healthcare sparked by Covid-19

Johnson & Johnson (NYSE: JNJ) agreed to buy Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) for about $6.5 billion to expand in treatments for autoimmune diseases. And Sanofi (NASDAQ: SNY) said it would buy biotech company Principia Biopharma Inc., which develops treatments for multiple sclerosis and a range of autoimmune disorders, for $3.4 billion, as the French drug maker pivots toward innovative therapies to spur growth.”

Biotech Debt is Through the Roof; Where to find value

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

If you could only own 3 stocks, what would they be?

Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) and cite that it’s like owning the greatest fund out there, but with one exception… It has the best manager. Warren Buffett just turned 90 years old, BRK is down 8% YTD, and we all remember what happened when Steve Jobs passed. There will be a better opportunity to own BRK sometime in the future.

The Top Diabetes Stocks for the remainder of 2020

Here is a company in the space that is finding its way onto the shelves of some major pharmacy retailers including Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and online at Amazon.com (NASDAQ: AMZN) yet is still trading below a $30 million valuation.

Healthcare Stocks and the cost of Medical

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Latest News